Official Malaysian Government Website
The information in this section is for health providers, such as doctors, pharmacists, nurses, medical assistants, etc. and not present as medical advice to health professionals.
Tell us
Please report ALL suspected Adverse Drug Reactions (ADRs) (including those for traditional products) and Adverse Events Following Immunisation (AEFIs) to the National Centre for Adverse Drug Reactions Monitoring. Do not hesitate to report if some details are not known. The identities of Reporter, Patient and Institution will remain confidential.
Please use this form to report for quality reporting of registered product (e.g. quality, efficacy, labelling, packaging) NOT related to ADRs.
Look it up
Search Pharmaceutical, Complimentary & Alternative Products that registered with National Pharmaceutical Regulatory Agency, NPRA. You may also search cosmetic products notified with NPRA.
View information regarding medicine shortage & Discontinuation.
Lot release
Non-compliance
Read
This report provides summarised updates on adverse events following immunisation (AEFIs) of COVID-19 Vaccines in Malaysia. The summary report is only available in English.
The MADRAC Bulletin provides information on the activities of the Malaysian Adverse Drug Reactions Advisory Committee, which meets bimonthly and advises the Drug Control Authority (DCA) on local and international drug safety issues.
This publication provides information and recommendations to healthcare professionals to enhance communication of drug safety updates, raise awareness of adverse drug reactions reported, and stimulate additional adverse drug reaction reporting.
Updates
Newsroom
